Phototherapy Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Flue Gas Desulfurization (FGD) Gypsum,Fluorogypsum,Phosphogypsum,Citrogypsum,Others), By Application (Cement,Drywall,Plaster,Soil Amendments,Glass Manufacturing,Water Treatment,Others), Regional Insights and Forecast to 2035

Phototherapy Equipment Market Overview

The global Phototherapy Equipment Market in terms of revenue was estimated to be worth USD 1993.16 Million in 2026 and is poised to reach USD 4007.64 Million by 2035, growing at a CAGR of 8.07% from 2026 to 2035.

The global Phototherapy Equipment Market had approximately 398.7 million units value in 2023 with installed base exceeding 500,000 clinical and home devices globally. The LED‑based devices captured about 48.2 % of global phototherapy units share and conventional fluorescent units held roughly 49.1 % of device volume in 2023. The neonatal jaundice application segment accounted for about 40 % of global volume installations.

In the USA market, phototherapy equipment reached device installation value of about 181.6 million USD equivalent and represented roughly 32.7 % of global share in 2023. The LED‑based phototherapy units comprised approximately 48.34 % of U.S. installed base in 2023, overtaking conventional devices.

Key Findings

• Key Market Driver: Around 56.4% of hospitals globally reported increased adoption of LED-based phototherapy devices due to enhanced energy efficiency and reduced treatment duration.
• Emerging Trends: Nearly 42.1% of healthcare providers shifted towards portable and home-use phototherapy units in 2023–2024 to improve patient accessibility.
• Regional Leadership: North America accounted for 32.7% of total phototherapy equipment installations, maintaining the highest share globally in 2023.
• Competitive Landscape: The top five market players controlled about 41.8% of the global device installation share in 2024.
• Market Segmentation: Neonatal jaundice applications contributed 40.2%, while dermatology applications held 59.8% of phototherapy usage worldwide.
• Recent Development: Around 28.3% of new product launches between 2023 and 2025 were focused on hybrid LED and fiber optic phototherapy systems.

Phototherapy Equipment Market Latest Trends

Phototherapy Equipment Market Trends in 2023–2025 show LED dominance, with LED units accounting for 48–55% of new installations and cutting energy use by 30–60% versus fluorescent systems that typically draw 200–400 W per device; leading LED bassinets operate at 70–110 W with irradiance stability within ±10%. Narrowband UVB at 311–313 nm represented 60–68% of dermatology treatment sessions, while targeted excimer solutions at 308 nm grew to 12–18% of clinic procedures.

NICU adoption of fiber‑optic phototherapy blankets covered 38–46% of facilities, with measured bilirubin reduction rates improving by 20–35% within 24–48 hours. Digital dosimetry, IoT uptime tracking above 97%, and UV sensors with 1–5 mW/cm² resolution enabled dose accuracy improvements of 15–25%. Teledermatology protocols linked to phototherapy scheduling rose in 28–36% of hospital networks.

Phototherapy Equipment Market Dynamics

DRIVER

"Rising neonatal hyperbilirubinemia cases and dermatology treatment volumes"

Neonatal jaundice affects 60–80% of newborns globally and up to 85–90% of preterm infants, creating continuous demand for blue‑light phototherapy cradles and fiber‑optic blankets across 12,000–15,000 NICUs worldwide. Dermatology workloads also underpin adoption: psoriasis prevalence ranges from 1.5–3.0% of adults, vitiligo affects 0.5–2.0%.

RESTRAINT

"High preference for refurbished and legacy fluorescent systems in cost‑sensitive settings"

Across lower‑income procurement cycles, 25–40% of acquisitions involve refurbished phototherapy towers, delaying fleet renewal by 3–5 years and limiting LED penetration to 45–55% of new placements in these markets. Fluorescent tubes require replacement every 800–1,200 hours, yet audit data show 18–28% of sites extend usage >1,500 hours, causing 10–20% drops .

OPPORTUNITY

"Expansion of home‑use phototherapy and connected care pathways"

Home‑use narrowband UVB hand‑helds and panels grew to 22–30% of total dermatology device shipments, while payer authorizations expanded in 10–14 large markets, cutting clinic visits by 2–3 per patient per month and saving 40–60 minutes of travel time per session. Remote protocols using smartphone imaging achieve 85–92% diagnostic concordance with in‑clinic grading .

CHALLENGE

"Dose‑safety compliance, standardization, and workflow constraints"

Regulatory dose limits require strict management of cumulative UV exposure; audits indicate 7–11% of sites record at least 1 out‑of‑tolerance event per 1,000 sessions due to sensor drift of 2–5% or improper patient distance by 3–8 cm. Erythema risk management compels patch‑testing in 100% of first‑time NB‑UVB patients and shielding for 100% of eyes and genitals, adding 5–10 minutes per setup .

Phototherapy Equipment Market Segmentation

The Phototherapy Equipment Market is segmented by product type and application. By type, LED phototherapy equipment held approximately 48 % of device share in 2023 showing rapid growth; conventional phototherapy equipment contributed around 49 % share; fiber optic phototherapy equipment provided 2–3 % of unit deployment.

BY TYPE

FGD Gypsum : LED systems generated 48.4 % share of global phototherapy device shipments in 2023, rising from 43 % in 2021. Average unit irradiance improved by 15 % between 2021 and 2023. In neonatal devices, LED blankets represented 52 % of new neonatal unit installations in 2023.

The FGD gypsum segment is estimated at USD 1,980 Million, securing 29.4% global share, advancing at 6.0% CAGR through the forecast horizon, supported by compliance-led supply availability and steady wallboard consumption across infrastructure, housing.

Top 5 Major Dominant Countries in the FGD Gypsum Segment

• United States: Estimated USD 360 Million, about 18.2% of the FGD segment, growing at 5.3% CAGR, propelled by stable drywall demand, renovation cycles, and consistent flue‑gas desulfurization byproduct streams from power generation assets.
• China: Around USD 410 Million, nearly 20.7% share, expanding at 6.6% CAGR, supported by robust construction activity, large gypsum board capacity, and policy-driven use of industrial byproducts .
• Germany: Approximately USD 165 Million, 8.3% share, with 4.9% CAGR, leveraging circular-economy practices, high renovation intensity, and stringent environmental standards that sustain dependable FGD gypsum supply for wallboard producers.
• India: About USD 195 Million, 9.8% share, achieving 7.2% CAGR, led by urban housing programs, commercial construction, and accelerating adoption of gypsum boards for speed, weight reduction, and improved interior .
• Japan: Estimated USD 150 Million, 7.6% share, posting 3.9% CAGR, supported by refurbishment demand, earthquake-resilient interior systems, and efficient collection channels .

Fluoro gypsum : Conventional phototherapy equipment comprised approximately 49 % of device share in 2023 and declined from 52 % in 2020. Fluorescent lamp systems represented 60 % of conventional segment; compact fluorescent lamps (CFL) made up 40 % of the conventional base.

Fluoro gypsum is assessed at USD 690 Million, accounting for 10.3% share, with 4.7% CAGR, driven by niche cement blends and plaster uses where regulatory alignment and cost advantages enable industrial byproduct valorization in construction materials.

Top 5 Major Dominant Countries in the Fluorogypsum Segment

• United States: Near USD 120 Million, 17.4% share, growing 4.2% CAGR, supported by specialty cement additives, local processing capacity, and compliance frameworks enabling controlled uptake of fluorogypsum.
• China: Around USD 185 Million, 26.8% share, expanding 5.3% CAGR, underpinned by scale in fluorochemical industries and downstream cement and plaster channels utilizing processed fluorogypsum within specification limits.
• Germany: Approximately USD 85 Million, 12.3% share, at 3.8% CAGR, benefiting from recycling mandates, traceability systems, and industrial partnerships integrating fluorogypsum in targeted binders and screeds.
• India: About USD 95 Million, 13.8% share, posting 5.6% CAGR, propelled by cost sensitivity in cement blending, proximity to fluorochemical clusters, and incremental adoption in non-structural applications.
• Japan: Estimated USD 70 Million, 10.1% share, with 3.1% CAGR, supported by quality-focused processing, consistent end‑use standards, and measured incorporation in plaster-based interior solutions.

Phospho gypsum : Phototherapy equipment represented just 2.6 % of global device installations in 2023. Use of fiber‑optic biliblankets in neonatal care grew by 15 % share in 2023 but remains niche due to cost. In homecare, fiber‑optic blankets held 5 % of home unit share.

Phospho gypsum reaches USD 1,420 Million, capturing 21.1% share, recording 5.4% CAGR, as regulated reuse pathways in cement, soil amendments, and road base applications broaden, while technology improvements address radionuclide and impurity management.

Top 5 Major Dominant Countries in the Phosphogypsum Segment

• United States: Approximately USD 240 Million, 16.9% share, at 4.6% CAGR, supported by pilot reuse programs, regional construction demand, and advancing beneficiation that elevates acceptance in compliant end uses.
• China: About USD 360 Million, 25.4% share, growing 6.2% CAGR, driven by large phosphate fertilizer output, maturing purification technologies, and scaling utilization in cement and road materials.
• India: Near USD 215 Million, 15.1% share, with 5.9% CAGR, propelled by fertilizer industry byproduct availability, soil amendment trials.
• Morocco: Estimated USD 175 Million, 12.3% share, posting 5.1% CAGR, leveraging substantial phosphate reserves, process integration, and export-oriented value chains for compliant applications.
• Brazil: Around USD 150 Million, 10.6% share, advancing 5.4% CAGR, buoyed by agronomic programs, regional construction demand, and gradual regulatory clarity on controlled uses.

Citrogypsum: Hospitals installed 90 % of fiber‑optic units due to higher pricing; only 10 % of these units were used in non‑hospital settings. Device adoption in North America and Europe was 3 % of type share, while Asia‑Pacific and MEA were under 1 %.

stands at USD 520 Million, representing 7.7% share, progressing at 4.2% CAGR, enabled by predictable purity profiles from citric acid production and consistent suitability for plaster and cement extender applications.

Top 5 Major Dominant Countries in the Citrogypsum Segment

• United States: Roughly USD 95 Million, 18.3% share, at 3.8% CAGR, benefiting from stable citric processing, reliable logistics to plaster plants, and demand from interior finishing markets.
• China: About USD 135 Million, 26.0% share, with 4.8% CAGR, supported by strong downstream plasterboard consumption and localized industrial symbiosis.
• Germany: Estimated USD 70 Million, 13.5% share, growing 3.6% CAGR, driven by quality controls, recycling targets, and specialized gypsum formulations.
• India: Around USD 85 Million, 16.3% share, advancing 4.9% CAGR, propelled by cost-effective extender usage in cement, expanding plaster markets.
• Japan: Approximately USD 55 Million, 10.6% share, with 3.0% CAGR, reflecting steady renovation demand and stringent product consistency needs.

BY APPLICATION

Cement : Phototherapy device usage in 2023. Psoriasis accounted for 36 % of skin application deployments, vitiligo 22 %, eczema 18 %, acne 14 %, others 10 %. LED phototherapy captured 53 % of skin‑application share in 2023, up from 48 % in 2021. Mobile units were widely used in outpatient dermatology.

Cement applications account for USD 2,100 Million, capturing 36.7% share, expanding at 5.4% CAGR, supported by cost‑efficient blending, strength performance, and growing infrastructure and commercial construction pipelines across priority geographies.

Top 5 Major Dominant Countries in the Cement Application

• United States: About USD 360 Million, 17.1% of cement use, at 4.9% CAGR, driven by highway upgrades, nonresidential builds, and steady adoption of synthetic gypsum extenders to optimize clinker .
• China: Roughly USD 540 Million, 25.7% share, growing 6.0% CAGR, supported by large-scale infrastructure, urban redevelopment, and integrated processing lines that ensure reliable gypsum quality for high-volume blended cements and regional logistics advantages.
• India: Approximately USD 310 Million, 14.8% share, advancing 6.3% CAGR, propelled by affordable housing, smart city projects, and cost-sensitive cement producers incorporating compliant gypsum streams to enhance setting control.
• Germany: Near USD 210 Million, 10.0% share, posting 4.2% CAGR, enabled by circular-economy rules, close supplier–mill partnerships, and premium specifications for performance cements in public infrastructure and industrial projects.
• Brazil: About USD 185 Million, 8.8% share, at 5.1% CAGR, underpinned by transport corridors, logistics hubs, and broader acceptance of processed gypsum in regional cement standards to stabilize quality and mitigate production costs.

Drywall: Drywall applications represented 31.2 % of global phototherapy device deployment in 2023. LED neonatal units held 52 % of neonatal application share, conventional units 45 %, fibre‑optic blankets 3 %.

Drywall consumes USD 1,850 Million, equating to 32.4% share, rising at 6.1% CAGR, supported by lightweight interior systems, refurbishment activity, and accelerating residential completions across developed and fast‑urbanizing markets.

Top 5 Major Dominant Countries in the Drywall Application

• United States: Around USD 470 Million, 25.4% share, with 5.6% CAGR, propelled by housing starts, office renovations, and a dense network of wallboard plants utilizing consistent gypsum feedstocks and recycling programs for cost .
• China: Approximately USD 430 Million, 23.2% share, at 6.6% CAGR, supported by commercial interiors, hospitality, and educational builds, plus integrated supply from power and process industries delivering dependable gypsum quality.
• Germany: Near USD 170 Million, 9.2% share, growing 4.7% CAGR, benefiting from energy-efficient retrofits, acoustic performance requirements, and stringent quality protocols across drywall systems for public buildings and healthcare facilities.
• India: About USD 210 Million, 11.4% share, advancing 7.0% CAGR, driven by speed-of-build advantages, retail fit‑outs, and preference for dry construction in high-density urban projects seeking faster occupancy and reduced structural loads.
• Japan: Roughly USD 140 Million, 7.6% share, at 3.8% CAGR, supported by refurbishment cycles, seismic design considerations, and premium interior finishing standards favoring uniform gypsum board performance and low-waste installation methods.

Plaster: Hospital NICU deployment accounted for 95 % of neonatal units; homecare neonatal units contributed 5 %. In 2023 Africa and Asia‑Pacific regions together installed over 60 % of neonatal units, while North America installed 25 % and Europe 15 %.

Plaster applications total USD 690 Million, securing 12.1% share, progressing at 4.6% CAGR, anchored by decorative finishes, patching compounds, and specialty interior products across residential and commercial refurbishment markets.

Top 5 Major Dominant Countries in the Plaster Application

• United States: About USD 120 Million, 17.4% share, growing 4.0% CAGR, supported by remodeling, heritage restorations, and specialty compounds for healthcare and hospitality interior standards emphasizing smoothness and durability.
• China: Approximately USD 165 Million, 23.9% share, at 5.1% CAGR, propelled by interior fit‑outs in mixed‑use developments and supply-side consistency from synthetic gypsum streams tailored to plaster purity specifications.
• Germany: Near USD 80 Million, 11.6% share, with 3.9% CAGR, aligned with energy upgrades, artisan finishes, and stringent labeling for low‑VOC, high-consistency plaster formulations demanded by professional contractors.
• India: Roughly USD 95 Million, 13.8% share, posting 5.3% CAGR, driven by rapid urban interiors, retail rollouts, and training-led adoption of ready‑mix plasters improving site productivity and finish uniformity.
• Italy: Around USD 60 Million, 8.7% share, expanding 3.6% CAGR, underpinned by architectural finishes, renovation programs, and specialty gypsum plasters for decorative and restoration applications .

Soil: In homecare, fiber‑optic blankets held 5 % of home unit share. Hospitals installed 90 % of fiber‑optic units due to higher pricing; only 10 % of these units were used in non‑hospital settings. Device adoption in North America and Europe was 3 % of type share, while Asia‑Pacific and MEA were under 1 %.

Soil amendments represent USD 480 Million, 8.4% share, accelerating at 5.2% CAGR, supported by agronomic programs using gypsum for calcium supply, sodic soil remediation, improved infiltration, and nutrient management.

Top 5 Major Dominant Countries in the Soil Amendments Application

• United States: Roughly USD 95 Million, 19.8% share, at 4.8% CAGR, driven by specialty crops, turf, and conservation districts promoting gypsum use for structure improvement, runoff reduction, and enhanced fertilizer efficiency.
• India: Around USD 90 Million, 18.8% share, advancing 5.7% CAGR, supported by reclamation of sodic soils, extension services, and cost-effective logistics from fertilizer and industrial hubs supplying agricultural gypsum.
• China: Approximately USD 110 Million, 22.9% share, growing 5.5% CAGR, propelled by large-acreage programs, soil health initiatives, and regional integration of processed gypsum with established ag‑input distributors.
• Brazil: Near USD 80 Million, 16.7% share, at 5.1% CAGR, aligned with Cerrado soil management, rainfall-driven leaching mitigation, and calcium–sulfur nutrition strategies for soy, corn, and sugarcane rotations.
• Australia: About USD 55 Million, 11.5% share, posting 4.6% CAGR, underpinned by broadacre reclamation, pasture improvement, and proximity to processing facilities enabling economical agricultural-grade gypsum supply.

Water treatment: Hospitals deployed 95 % of fiber‑optic units, with homecare taking 5 %. Average operating hours per LED unit were measured at 1,600 hours per year. Regulatory approvals were cleared for 72 % of new device models within 12 months in U.S. FDA in 2023.

Water treatment consumes USD 160 Million, 2.8% share, advancing 4.1% CAGR, with targeted uses in pH control, coagulation, and specialized process streams where regulated gypsum-based inputs are suitable.

Top 5 Major Dominant Countries in the Water Treatment Application

• United States: Approximately USD 35 Million, 21.9% share, with 3.9% CAGR, led by industrial water programs and municipal pilots integrating gypsum-derived inputs under rigorous compliance.
• China: Around USD 40 Million, 25.0% share, growing 4.6% CAGR, supported by industrial clusters, reuse mandates, and cost-focused adoption in compatible treatment trains.
• Germany: Near USD 22 Million, 13.8% share, at 3.1% CAGR, aligned with circular-resource initiatives and traceable sourcing standards.
• India: Roughly USD 28 Million, 17.5% share, posting 4.7% CAGR, driven by industrial effluent management and municipal modernization.
• Japan: About USD 18 Million, 11.3% share, recording 2.8% CAGR, reflecting conservative but steady niche deployments.

Phototherapy Equipment Market Regional Outlook

Regional performance varied: North America led with roughly 39 % of global device share, Europe followed with about 29 %, Asia‑Pacific held around 24 %, and Middle East & Africa covered approximately 8 %. North America installations totaled over 220 million device units in 2024, Europe over 190 million, Asia‑Pacific 145 million, MEA about 50 million.

North America

North America dominated the Phototherapy Equipment Market Market, holding approximately 39 % share of total device installations in 2023. The U.S. accounted for about 204 million unit market size in 2024, Canada represented another 16 million units. LED phototherapy equipment constituted 52 % of all units in North America in 2023, up from 48 % in 2021.

North America reaches USD 1,640 Million, holding 28.7% share, expanding 5.4% CAGR, supported by renovation-led drywall demand, infrastructure bills, and mature recycling networks streamlining gypsum availability for board, cement, and specialty uses.

North America - Major Dominant Countries in the “Phototherapy Equipment Market”

• United States: About USD 1,250 Million, 76.2% regional share, at 5.1% CAGR, propelled by housing starts, large wallboard capacity, cement blending programs, and circular initiatives recovering gypsum from construction and demolition streams.
• Canada: Approximately USD 220 Million, 13.4% share, growing 5.3% CAGR, supported by residential completions, energy‑efficient retrofits, and proximity of processing hubs to major metropolitan corridors in Ontario, Quebec, and the West.
• Mexico: Near USD 95 Million, 5.8% share, at 6.0% CAGR, benefiting from nearshoring investment, industrial parks, and board plants supplying commercial interiors and export markets.
• Puerto Rico: Roughly USD 35 Million, 2.1% share, posting 3.4% CAGR, driven by reconstruction cycles, healthcare facility upgrades, and logistics links to mainland processing.
• Dominican Republic: Around USD 40 Million, 2.4% share, with 4.2% CAGR, reflecting hospitality construction, retail fit‑outs, and regional sourcing agreements.

Europe

Europe accounted for approximately 29 % of global phototherapy equipment installations in 2023. Countries such as UK, Germany, France, Italy and Spain collectively contributed over 70 % of that European share. LED phototherapy equipment comprised 50 % of European installations in 2023, up from 45 % in 2020.

Europe totals USD 1,520 Million, securing 26.6% share, advancing 4.6% CAGR, anchored by renovation intensity, public procurement standards, and strict waste directives accelerating reclaimed and synthetic gypsum use across board, plaster, and cement applications.

Europe - Major Dominant Countries in the “Phototherapy Equipment Market”

• Germany: About USD 420 Million, 27.6% regional share, at 4.2% CAGR, driven by energy retrofits, premium drywall, and circular mandates enabling steady synthetic and recycled gypsum supply to integrated manufacturers.
• United Kingdom: Approximately USD 285 Million, 18.8% share, growing 4.7% CAGR, supported by housing refurbishments, education builds, and increasing recovery of plasterboard waste .
• France: Near USD 260 Million, 17.1% share, posting 4.4% CAGR, propelled by public infrastructure, healthcare interiors, and standardized quality controls for gypsum inputs.
• Italy: Roughly USD 230 Million, 15.1% share, with 4.0% CAGR, aligned with seismic retrofits, hospitality upgrades, and specialty plasters.
• Spain: Around USD 210 Million, 13.8% share, at 4.6% CAGR, aided by residential upgrades, tourism-related construction, and regional wallboard capacity expansions.

Asia‑Pacific

Asia‑Pacific held approximately 24 % of global phototherapy equipment device installations in 2023. Nations such as China, India, Japan, South Korea and Australia made up over 70 % of APAC share. LED devices accounted for 46 % of APAC installations; conventional equipment held 52 %; fibre‑optic units covered 2 %.

Asia achieves USD 1,980 Million, 34.6% share, expanding 6.1% CAGR, underpinned by urbanization, commercial interiors, and extensive integration of synthetic gypsum sources across wallboard, cement, and agricultural channels.

Asia - Major Dominant Countries in the “Phototherapy Equipment Market Market”

• China: Approximately USD 1,050 Million, 53.0% regional share, at 6.4% CAGR, driven by large wallboard systems, road materials, and cement blending supported by mature collection.
• India: About USD 470 Million, 23.7% share, growing 6.7% CAGR, propelled by housing programs, retail expansion, and agronomic gypsum adoption for soil health.
• Japan: Near USD 200 Million, 10.1% share, with 3.8% CAGR, supported by refurbishment cycles, seismic-priority interiors, and high-spec supply chains.
• South Korea: Roughly USD 135 Million, 6.8% share, posting 4.1% CAGR, aligned with premium interiors and industrial efficiency.
• Indonesia: Around USD 125 Million, 6.3% share, at 5.3% CAGR, reflecting urban housing, hospitality, and cost-optimized cement use.

Middle East & Africa

Middle East & Africa represented about 8 % of global phototherapy equipment installations in 2023, totaling over 50 million device‑hours. Skin disease treatment constituted 65 %; neonatal jaundice units were 35 %. Hospitals and clinics used 88 % of installations; homecare only 12 %.

Middle East and Africa represent USD 580 Million, 10.1% share, advancing 5.0% CAGR, supported by mega‑projects, social housing, and cement blending economics, with growing drywall penetration in commercial and residential interiors.

Middle East and Africa - Major Dominant Countries in the “Phototherapy Equipment Market”

• Saudi Arabia: About USD 165 Million, 28.4% regional share, at 5.4% CAGR, propelled by giga‑projects, building code modernization, and regional board manufacturing.
• United Arab Emirates: Approximately USD 120 Million, 20.7% share, growing 4.8% CAGR, driven by hospitality, retail, and high‑spec interiors requiring consistent gypsum inputs.
• South Africa: Near USD 95 Million, 16.4% share, with 4.5% CAGR, aligned with commercial refurbishments and cement blending initiatives.
• Egypt: Roughly USD 105 Million, 18.1% share, posting 5.2% CAGR, supported by new urban communities and integrated supply chains.
• Nigeria: Around USD 95 Million, 16.4% share, at 5.0% CAGR, reflecting urbanization, retail development, and cost-focused cement markets.

List of Top Phototherapy Equipment Market Companies

• Georgia-Pacific Gypsum LLC
• British Gypsum
• KNAUF GIPS
• FEECO international
• National Gypsum
• USG Corporation
• Saint-Gobain Construction Products
• Lafarge Holcim
• Synthetic Materials LLC
• PABCO Building Products
• LLC
• Constantia Building Products
• Delta Gypsum
• Gyptec IBERICA
• American Gypsum

Investment Analysis and Opportunities

Investment activity in the Phototherapy Equipment Market Market shows capital deployment in R&D and product expansion. In 2023, industry investment totaled over 150 million USD in new device platforms, representing 12 % of total medical device R&D. Approximately 28 % of venture funding in neonatal devices was allocated to LED mobile systems.

Expansion opportunities exist in Asia‑Pacific neonatal and homecare segments, where installations grew by 60 % combined in 2022–2023. Regions such as India and China saw unit installations rise from 20 million to 35 million units between 2021 and 2023, indicating investment opportunity.

New Product Development

Manufacturers have introduced multiple innovative phototherapy product lines in 2023–2025. LED mobile units with adjustable wavelength control have increased usage by 28 % share in 2023. Battery‑powered portable neonatal LED blankets launched in 2023 gained 22 % homecare adoption.

Smart phototherapy devices with IoT connectivity and treatment tracking represented 30 % of new device launches in 2023. AI‑integrated LED units that adjust irradiance based on skin pigment were rolled out in 15 countries in 2024, capturing 12 % of skin‑treatment installations. Devices offering remote controller interfaces for ambulatory use saw homecare share rise by 18 %.

Five Recent Developments

• LED : mobile phototherapy device shipments rose by 28 % share globally in 2023, expanding leadership in ambulatory units.
• Homecare LED: biliblankets adoption increased by 22 % share in 2023 compared to 2021 baseline.
• Smart : connected phototherapy units with IoT tracking comprised 30 % of all new products launched in 2024.

• Fiber‑optic: neonatal devices increased type share from 2 % to 2.6 % in 2023, following new rechargeable models.
• In India and China: combined installations grew from 20 million to 35 million device units from 2021 to 2023, pushing Asia‑Pacific share to 24 %.

Report Coverage of Phototherapy Equipment Market

This Phototherapy Equipment Market Report covers detailed quantitative analysis of installed device units, segmentation by product type and application. It includes unit shipment statistics across LED phototherapy equipment (48 % share), conventional equipment (49 %), and fiber optic units (2.6 %) as of 2023.

End‑user segmentation includes hospitals and clinics (81.8 %) and homecare settings (18.2 %). Regional coverage spans North America (39 % share), Europe (29 %), Asia‑Pacific (24 %) and Middle East & Africa (8 %), with per‑country unit figures such as USA 204 million units, Canada 16 million, China 35 million, India 25 million, Europe lead countries UK/Germany/France combined over 70 % of regional share.

Phototherapy Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1993.16 Million in 2026
Market Size Value By	USD 4007.64 Million by 2035
Growth Rate	CAGR of 8.07% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Flue Gas Desulfurization (FGD) Gypsum Fluorogypsum Phosphogypsum Citrogypsum Others By Application : Cement Drywall Plaster Soil Amendments Glass Manufacturing Water Treatment Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample